All In MedTech

FDA Clearance Tracker · P160017-S017

MiniMed 670G System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 13, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 13, 2018

Approved

Time to decision

195 days

Received Aug 2, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P160017-S017
Device name
MiniMed 670G System
Applicant location
Northridge, CA
Received
Aug 2, 2017
Decided
Feb 13, 2018
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P160017

Device type

Device class
Class III

Every decision under product code OZP

FDA's approval statement

As written in FDA's record.

Approval for adding the upper arm as an alternate insertion site for the Guardian Sensor (3).

Source documents

Other decisions for Medtronic Minimed, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.